$0.1292
0.006705.47%
At close: -
Comments
Loading...
Delivra Health Brands Analyst Ratings and Price Targets | OTC:DHBUF | Benzinga
Delivra Health Brands Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Delivra Health Brands Corp from these most-recent analyst ratings.
Analyst Ratings for Delivra Health Brands
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Delivra Health Brands (DHBUF) stock?
There is no price target for Delivra Health Brands
What is the most recent analyst rating for Delivra Health Brands (DHBUF)?
There is no analyst for Delivra Health Brands
When was the last upgrade for Delivra Health Brands (DHBUF)?
There is no last upgrade for Delivra Health Brands
When was the last downgrade for Delivra Health Brands (DHBUF)?
There is no last downgrade for Delivra Health Brands.
When is the next analyst rating going to be posted or updated for Delivra Health Brands (DHBUF)?
There is no next analyst rating for Delivra Health Brands.
Is the Analyst Rating Delivra Health Brands (DHBUF) correct?
There is no next analyst rating for Delivra Health Brands.
Browse analyst ratings and price targets on all stocks.
